MetLife Investment Management’s Align Technology ALGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.57M Sell
15,240
-358
-2% -$62.1K 0.01% 1003
2026
Q1
$2.67M Sell
15,598
-426
-3% -$74.6K 0.01% 910
2025
Q4
$2.5M Sell
16,024
-718
-4% -$103K 0.01% 964
2025
Q3
$2.1M Buy
+16,742
New +$2.62M 0.01% 1068
2025
Q2
Sell
-20,221
Closed -$3.21M 2761
2025
Q1
$3.21M Sell
20,221
-371
-2% -$72.8K 0.02% 828
2024
Q4
$4.29M Buy
20,592
+254
+1% +$56.7K 0.02% 649
2024
Q3
$5.17M Sell
20,338
-461
-2% -$109K 0.03% 508
2024
Q2
$5.02M Buy
20,799
+866
+4% +$241K 0.03% 487
2024
Q1
$6.54M Sell
19,933
-602
-3% -$177K 0.04% 371
2023
Q4
$5.63M Sell
20,535
-351
-2% -$83.2K 0.04% 393
2023
Q3
$6.38M Sell
20,886
-458
-2% -$158K 0.05% 316
2023
Q2
$7.55M Buy
21,344
+127
+0.6% +$40.4K 0.06% 283
2023
Q1
$7.09M Sell
21,217
-28
-0.1% -$8.26K 0.05% 301
2022
Q4
$4.48M Sell
21,245
-410
-2% -$82.1K 0.03% 506
2022
Q3
$4.48M Sell
21,655
-420
-2% -$108K 0.04% 465
2022
Q2
$5.22M Sell
22,075
-1,323
-6% -$406K 0.04% 397
2022
Q1
$10.2M Buy
23,398
+7,380
+46% +$3.59M 0.07% 238
2021
Q4
$10.5M Sell
16,018
-341
-2% -$219K 0.09% 184
2021
Q3
$10.9M Sell
16,359
-104
-0.6% -$70.6K 0.1% 162
2021
Q2
$10.1M Sell
16,463
-464
-3% -$275K 0.09% 183
2021
Q1
$9.17M Sell
16,927
-266
-2% -$147K 0.08% 200
2020
Q4
$9.19M Sell
17,193
-749
-4% -$337K 0.09% 183
2020
Q3
$5.87M Sell
17,942
-646
-3% -$197K 0.06% 276
2020
Q2
$5.1M Buy
18,588
+101
+0.5% +$22.7K 0.06% 302
2020
Q1
$3.22M Sell
18,487
-566
-3% -$136K 0.04% 409
2019
Q4
$5.32M Sell
19,053
-727
-4% -$181K 0.06% 321
2019
Q3
$3.58M Sell
19,780
-288
-1% -$59.9K 0.04% 500
2019
Q2
$5.49M Sell
20,068
-42,029
-68% -$12.7M 0.06% 310
2019
Q1
$17.7M Buy
62,097
+41,272
+198% +$9.85M 0.05% 272
2018
Q4
$4.36M Sell
20,825
-447
-2% -$113K 0.05% 338
2018
Q3
$8.32M Buy
21,272
+37
+0.2% +$13.7K 0.09% 207
2018
Q2
$7.26M Sell
21,235
-469
-2% -$140K 0.09% 200
2018
Q1
$5.45M Sell
21,704
-623
-3% -$160K 0.06% 292
2017
Q4
$4.96M Buy
+22,327
New +$5.07M 0.06% 335

Other funds holding ALGN

MetLife Investment Management's ALGN Position: Q2 2026 in Review

MetLife Investment Management reduced its Align Technology (ALGN) stake by 2.3% in Q2 2026, selling an estimated $62.1K and leaving 15,240 shares worth $2.57M. The position accounts for 0.01% of the portfolio, ranked #1003.

MetLife Investment Management first reported a position in ALGN in Q4 2017 and has held it in 34 quarters since. The position peaked at $17.7M in Q1 2019. 671 funds tracked by Wall St. Rank hold ALGN as of Q2 2026.

  • MetLife Investment Management held 15,240 shares of Align Technology worth $2.57M as of Q2 2026.
  • MetLife Investment Management sold 358 Align Technology shares in Q2 2026, an estimated $62.1K.
  • Align Technology made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1003 holding.
  • MetLife Investment Management first reported a position in Align Technology in Q4 2017 and has held it in 34 quarters since.
  • MetLife Investment Management's Align Technology position peaked at $17.7M in Q1 2019.
  • 671 funds tracked by Wall St. Rank held Align Technology as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.